CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo
Keun-Yong Eom, Bong Jun Cho, Eun Jung Choi, Jin-Ho Kim, Eui Kyu Chie, Hong-Gyun Wu, Il Han Kim, Sun Ha Paek, Jae-Sung Kim, In Ah Kim
Cancer Research and Treatment. 2016;48(2):687-697.   Published online 2015 June 4    DOI: https://doi.org/10.4143/crt.2014.320

Excel Download

The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo
Cancer Research and Treatment. 2016;48(2):687-697   Crossref logo
Link1 Link2 Link3

Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2
Cancer Letters. 2011;310(2):188-197   Crossref logo
Link1 Link2

Apoptotic effect of PP2 a Src tyrosine kinase inhibitor, in murine B cell leukemia
Journal of Cellular Biochemistry. 2004;93(3):629-638   Crossref logo
Link1 Link2

Development of a novel bone-targeted Src tyrosine kinase inhibitor AP23451 having potent in vitro and in vivo anti-tesorptive properties
European Journal of Haematology. 2003;70(4):271-271   Crossref logo
Link1 Link2 Link3

BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo
OncoTargets and Therapy. 2015;689   Crossref logo
Link1

Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2
Biochemical and Biophysical Research Communications. 2006;350(2):450-456   Crossref logo
Link1 Link2

Knockout of ATG5 leads to malignant cell transformation and resistance to Src family kinase inhibitor PP2
Journal of Cellular Physiology. 2017;233(1):506-515   Crossref logo
Link1 Link2

596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts
European Journal of Cancer Supplements. 2008;6(12):186-187   Crossref logo
Link1 Link2

510 Inhibition of STAT3 enhances the radiosensitising effect of temozolomide in malignant glioma cells in vitro and in vivo
European Journal of Cancer. 2014;50:166   Crossref logo
Link1 Link2

Temozolomide in malignant glioma
OncoTargets and Therapy. 2010;139   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.